Cargando…
Measuring mobility in older hospital patients with cognitive impairment using the de Morton Mobility Index
BACKGROUND: Mobility is a key outcome in older patients with cognitive impairment. The de Morton Mobility Index (DEMMI) is an established measure of older people’s mobility that is promising for use in older patients with cognitive impairment. The aim of this study was to examine the DEMMI’s psychom...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913915/ https://www.ncbi.nlm.nih.gov/pubmed/29685107 http://dx.doi.org/10.1186/s12877-018-0780-9 |
_version_ | 1783316627768475648 |
---|---|
author | Braun, Tobias Grüneberg, Christian Thiel, Christian Schulz, Ralf-Joachim |
author_facet | Braun, Tobias Grüneberg, Christian Thiel, Christian Schulz, Ralf-Joachim |
author_sort | Braun, Tobias |
collection | PubMed |
description | BACKGROUND: Mobility is a key outcome in older patients with cognitive impairment. The de Morton Mobility Index (DEMMI) is an established measure of older people’s mobility that is promising for use in older patients with cognitive impairment. The aim of this study was to examine the DEMMI’s psychometric properties in older patients with dementia, delirium or other cognitive impairment. METHODS: This cross-sectional study was performed in a geriatric hospital and includes older acute medical patients with cognitive impairment indicated by a Mini Mental State Examination (MMSE) score ≤ 24 points. A Rasch analysis was performed to check the DEMMI’s unidimensionality. Construct validity was assessed by testing 13 hypotheses about expected correlations between the DEMMI and outcome measures of similar or related constructs, and about expected differences of DEMMI scores between groups differing in mobility related characteristics. Administration times were recorded. RESULTS: A sample of 153 patients with mild (MMSE 19–24 points; 63%) and moderate (MMSE: 10–18 points; 37%) cognitive impairment was included (age range: 65–99 years; mean MMSE: 19 ± 4, range: 8–24 points; diagnosis of dementia and delirium: 40% and 18%, respectively). Rasch analysis indicated unidimensionality with an overall fit to the model (P = 0.107). Internal consistency reliability was excellent (Cronbach’s alpha = 0.92). Eleven out of 13 (85%) hypotheses on construct validity were confirmed. The DEMMI showed good feasibility, and no adverse events occurred. The mean administration time of 5 min (range: 1–10) was not influenced by the level of cognitive impairment. In contrast to some other comparator instruments, no floor or ceiling effects were evident for the DEMMI. CONCLUSIONS: Results indicate sufficient psychometric properties of the DEMMI in older patients with cognitive impairment. TRIAL REGISTRATION: German Clinical Trials Register (DRKS00005591). Registered February 2, 2015. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12877-018-0780-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5913915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59139152018-04-30 Measuring mobility in older hospital patients with cognitive impairment using the de Morton Mobility Index Braun, Tobias Grüneberg, Christian Thiel, Christian Schulz, Ralf-Joachim BMC Geriatr Research Article BACKGROUND: Mobility is a key outcome in older patients with cognitive impairment. The de Morton Mobility Index (DEMMI) is an established measure of older people’s mobility that is promising for use in older patients with cognitive impairment. The aim of this study was to examine the DEMMI’s psychometric properties in older patients with dementia, delirium or other cognitive impairment. METHODS: This cross-sectional study was performed in a geriatric hospital and includes older acute medical patients with cognitive impairment indicated by a Mini Mental State Examination (MMSE) score ≤ 24 points. A Rasch analysis was performed to check the DEMMI’s unidimensionality. Construct validity was assessed by testing 13 hypotheses about expected correlations between the DEMMI and outcome measures of similar or related constructs, and about expected differences of DEMMI scores between groups differing in mobility related characteristics. Administration times were recorded. RESULTS: A sample of 153 patients with mild (MMSE 19–24 points; 63%) and moderate (MMSE: 10–18 points; 37%) cognitive impairment was included (age range: 65–99 years; mean MMSE: 19 ± 4, range: 8–24 points; diagnosis of dementia and delirium: 40% and 18%, respectively). Rasch analysis indicated unidimensionality with an overall fit to the model (P = 0.107). Internal consistency reliability was excellent (Cronbach’s alpha = 0.92). Eleven out of 13 (85%) hypotheses on construct validity were confirmed. The DEMMI showed good feasibility, and no adverse events occurred. The mean administration time of 5 min (range: 1–10) was not influenced by the level of cognitive impairment. In contrast to some other comparator instruments, no floor or ceiling effects were evident for the DEMMI. CONCLUSIONS: Results indicate sufficient psychometric properties of the DEMMI in older patients with cognitive impairment. TRIAL REGISTRATION: German Clinical Trials Register (DRKS00005591). Registered February 2, 2015. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12877-018-0780-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-23 /pmc/articles/PMC5913915/ /pubmed/29685107 http://dx.doi.org/10.1186/s12877-018-0780-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Braun, Tobias Grüneberg, Christian Thiel, Christian Schulz, Ralf-Joachim Measuring mobility in older hospital patients with cognitive impairment using the de Morton Mobility Index |
title | Measuring mobility in older hospital patients with cognitive impairment using the de Morton Mobility Index |
title_full | Measuring mobility in older hospital patients with cognitive impairment using the de Morton Mobility Index |
title_fullStr | Measuring mobility in older hospital patients with cognitive impairment using the de Morton Mobility Index |
title_full_unstemmed | Measuring mobility in older hospital patients with cognitive impairment using the de Morton Mobility Index |
title_short | Measuring mobility in older hospital patients with cognitive impairment using the de Morton Mobility Index |
title_sort | measuring mobility in older hospital patients with cognitive impairment using the de morton mobility index |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913915/ https://www.ncbi.nlm.nih.gov/pubmed/29685107 http://dx.doi.org/10.1186/s12877-018-0780-9 |
work_keys_str_mv | AT brauntobias measuringmobilityinolderhospitalpatientswithcognitiveimpairmentusingthedemortonmobilityindex AT grunebergchristian measuringmobilityinolderhospitalpatientswithcognitiveimpairmentusingthedemortonmobilityindex AT thielchristian measuringmobilityinolderhospitalpatientswithcognitiveimpairmentusingthedemortonmobilityindex AT schulzralfjoachim measuringmobilityinolderhospitalpatientswithcognitiveimpairmentusingthedemortonmobilityindex |